AXOVANT GENE THERAPIES LTD's ticker is and the CUSIP is G0750W953. A total of 3 filers reported holding AXOVANT GENE THERAPIES LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $47,000 | +487.5% | 10,100 | +236.7% | 0.00% | – |
| Q2 2020 | $8,000 | 0.0% | 3,000 | -6.2% | 0.00% | – |
| Q1 2020 | $8,000 | -94.8% | 3,200 | -89.4% | 0.00% | -100.0% |
| Q4 2019 | $155,000 | -9.9% | 30,300 | +13.9% | 0.00% | 0.0% |
| Q3 2019 | $172,000 | -41.3% | 26,600 | -43.4% | 0.00% | -66.7% |
| Q2 2019 | $293,000 | – | 47,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 3,200 | $8,000 | 0.00% |
| SIMPLEX TRADING, LLC | 181 | $43,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |